News

FINAL REMINDER: Biosimilar Switch Deadline – Humira, Enbrel, Lantus – November 30, 2022

November 30, 2022

The ETFO ELHT Benefits Plan announced in May 2022 that plan members or their dependants using Humira, Enbrel, and Lantus would be required to switch to the corresponding biosimilar effective September 1, 2022, with a transition period to December 1, 2022.   If you still have not made this switch by November 30, 2022, coverage will no longer be available for these three medications effective December 1, 2022. 

Find out more about this news item >

Winter 2022-2023 Issue: Your Benefits! Newsletter

November 29, 2022

Welcome to the thirteenth edition of Your Benefits! The Winter 2022/2023 includes the following articles:  Wellness is more than a hashtag;  Travelling over the holidays?  Providers say “use it or lose it” – we say use it well!

Find out more about this news item >

FINAL REMINDER: Premium Deductions switched to pre-authorized bank deductions (PAD) – deadline November 30, 2022

November 16, 2022

Effective September 1, 2022, plan members who are responsible for paying benefit premiums (**plan members with optional or supplemental life and/or part-time members with health and dental coverage) will now have premium deductions done by pre-authorized deductions (PAD) instead of via payroll deduction.  Those plan members** that have still not provided bank information to OTIP by November 30, 2022 will have applicable benefits terminated on December 1, 2022.

Find out more about this news item >
ETFO Employee Life and Health Trust (ELHT). All Rights Reserved | Privacy and Terms of Use